Two years after the appearance of the SARS-CoV-2 virus, the causal agent of the current
global pandemic, it is time to analyze the evolution of the immune protection that infection …

Recent evidence shows that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) is sensitive to interferons (IFNs). However, the most effective types of IFNs and the …

Abstract Background/Objectives The safety and immunogenicity of the BNT162b2
coronavirus disease 2019 (COVID‐19) vaccine in older adults with different frailty and …

ABSTRACT COVID-19, the disease caused by the novel severe acute respiratory syndrome-
associated coronavirus 2 (SARS-CoV-2), was first detected in December 2019 and has …

Main cause of severe illness and death in COVID-19 patients appears to be an excessive
but ineffectual inflammatory immune response that may cause severe acute respiratory …

The pandemic of the new coronavirus SARS-CoV-2 (severe acute respiratory syndrome
coronavirus 2) has led to the deaths of more than 1.5 million people worldwide. SARS-CoV …

T cells play a critical role in coronavirus diseases. How they do so in COVID-19 may be
revealed by analyzing the epigenetic chromatin accessibility of cis-and trans-regulatory …

An efficient host immune response is crucial in controlling viral infections. Despite most
studies focused on the implication of T and B cell response in COVID-19 (Corona Virus …

A key question in SARS-CoV-2 infection is why viral loads and patient outcomes vary
dramatically across individuals. Because spatial-temporal dynamics of viral spread and …

Infection with the novel pandemic SARS-CoV-2 virus has been shown to elicit a cross-
reactive immune response that could lead to a back-boost of memory recall to previously …